Posted inDiabetes & Endocrinology news
Metabolic and Muscular Impacts of Switching from Daily Somatropin to Weekly Somapacitan in Adult Growth Hormone Deficiency: Real-World Evidence
Switching from daily somatropin to once-weekly somapacitan in adults with growth hormone deficiency maintains lean mass, improves functional outcomes, but may increase adiposity indices, highlighting a trade-off in metabolic effects during routine care.
